Oncology Flashcards
Bleomycin MoA
induces free radical formation -> breaks DNA strands
Acts G2/M phase
Bleomycin used in?
testicular ca and hodgkins lymphoma
bleomycin ADRs
pulmonary fibrosis, skin hyperpigmentation, mucositis
Dactinomycin moa
intercalates into DNA -> prevents RNA synthesis
Uses of dacinomycin
wilms tumour, ewing sarcoma, rhabdomyosarcoma
Dactinomycin ADR
myelosuppression
Anthracyclines (doxorubicin and daunorubicin) MoA and use
generates free radicals
intercalates in DNA -> DNA breaks -> reduced DNA replication
inhibits topoisomerase 2
used in solid tumours, leukaemias, lymphoma
Anthracyclines (doxorubicin and daunorubicin) ADRs
dilated cardiomyopathy
myelosuppresion
alopecia
thiopurines MoA
purine analogs -> reduced de novo purine synthesis
AZA converted to 6-MP and activated by HGPRT
- inhibits PRPP-synthase and aminotransferase
thopurines ADRs
myelosuppression, GI/liver toxicity
6-MP inactivated by xanthine oxidase and TPMT (increased toxicity with allopurinol or feboxustat
Cladribine and pentostatin MoA
purine analogs -> unable to be processed by ADA -> reduced DNA synthesis and blocks DNA strand elongation
Cladribine and pentostatin use and ADR
in hairy cell leukaemia
ADR: myelosuppresion
Cytarabine MoA and use, ADR
pyrimidine analog -> DNA chain termination, inhibits DNA pol
used in AML, lymphoma
ADR: myelosuppresion
5-FU MoA
pyrimidine analog -> activated to 5-FdUMP which reduces DNA synthesis
capcitabine is a prodrug
what is used as 5-FU antidote
Uridine
What can enhance effects of 5-FU
folinic acid
ADRs of 5FU
myelosuppresion, hand-foot syndrome, photosensitivity
hydroxyurea MoA
inhibits ribonucleotide reductase -> reducing DNA synthesis
hydroxyurea ADRs
severe myelosuppresion, megaloblastic anameia
Methotrexate MoA
folic acid analog which inhibits dihydrofolate reductase -> reducing DNA synthesis
Methotrexate ADRs
myelosuppression
hepatotoxicity -> bx macrovesicular change
mucositis
pulmonary fibrosis
folate def
nephrotoxicity
busulfan MoA and use
cross links DNA -> cell death
used to ablate BM prior to transplant
busulfan ADRs
myelosuppression, pulmonary fibrosis, hyperpigmentation
cyclophosphamide, ifosfamide MoA
cross links DNA, needs activation in liver
cyclophosphamide, ifosfamide ADRs
myelosuppresion, SIADH, fanconi syndrome (ifosfamide - inadequate reabsorption in proximal tubules, reduced K and acidosis)
Haemorrhagic cystitis and bladder cancer (prevent with mesna)
carmustine, lomustine MoA and uses
cross link DNA, activates in liver
crosses BBB so used for brain tumours
carmustine, lomustine ADRs
CNS toxicity (dizziness, ataxia, seizures)